Almaden—which was formerly part of IBM Research before launching as a standalone company in 2022 under Catalyze Dallas ownership—aims to complement its g.nome workflow platform with the new service ...
Dallas-based Almaden Genomics—whose g.nome workflow platform aims to “democratize and accelerate bioinformatics by breaking down barriers in biotech R&D”—has launched a new Data Management and ...